Learning Objectives:

1. Review standard of care regarding management of mediastinal lymph nodes in patients with T1 or T2 NSCLC.

2. Determine whether MLND improves survival when compared to mediastinal lymph node sampling.

3. Develop teaching and effective presentation skills in form of lectures or discussions of various vascular topics, to a variety of audiences including medical students, residents, fellows, and physicians.

Session date: 
Tuesday, August 18, 2020 - 6:45am to 7:30am
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Dr. Philip Erwin